Job/Unit: O20879
/KAP1
Date: 27-08-12 18:56:11
Pages: 12
Turning On Fluorescence with Thiols
853 (w), 834 (vs), 787 (s), 721 (w), 696 (vs) cm–1. HRMS (EI, (w), 1698 (vs), 1604 (w), 1578 (w), 1532 (s), 1497 (w), 1456 (m),
70 eV): calcd. for C22H22N4O8 [M]+ 470.1438; found 470.1429.
1437 (m), 1420 (m), 1397 (s), 1359 (m), 1336 (m), 1216 (vs), 1175
(s), 1116 (s), 1074 (m), 1031 (w), 991 (w), 920 (w), 874 (w) cm–1.
HRMS (EI, 70 eV): calcd. for C36H38N4O8S2 [M]+ 718.2131; found
718.2148.
Dimethyl 2-[2-(3-Acetoxy-2,5-dioxopyrrolidin-1-yl)ethylamino]-5-[2-
(2,5-dioxo-2,5-dihydropyrrol-1-yl)ethylamino]terephthalate (NiWa
Orange II) (8): A solution of biscarbamate 6 (410 mg, 0.803 mmol)
in CH2Cl2 (4 mL) and TFA (2 mL) was stirred at 23 °C for 1 h.
Glacial acetic acid (3 mL) and maleic anhydride (315 mg,
3.21 mmol) were added, and the resulting mixture was further
heated at 90 °C for 2 d. The solution was then diluted with EtOAc
(90 mL) and H2O (40 mL), and the layers were separated. The or-
ganic layer was extracted with H2O (40 mL) and dried (MgSO4).
After filtration and evaporation, the residue was chromatographed
(SiO2, hexane/EtOAc 2:1 Ǟ 1:1 Ǟ 1:2). The first fraction [Rf (hex-
ane/EtOAc 1:2) = 0.43] contained compound 7 (56 mg, 0.12 mmol,
15%) as an orange solid. From the second fraction [Rf (hexane/
EtOAc 1:2) = 0.33], compound 8 (40 mg, 75 μmol, 9%) was isolated
Conversion of Bisimide 7 with Hexadecanethiol: A solution of 1-
hexadecanethiol (0.12 mmol, 8.1 mL, 0.015 molL–1 in CH2Cl2) was
added (cooling with an ice-water bath) to a solution of bismalein-
imide 7 (114 mg, 0.242 mmol) and NEt3 (100 mg, 0.988 mmol) in
CH2Cl2 (4 mL). The mixture was warmed to 23 °C and then stirred
for 24 h. The solvent was evaporated under reduced pressure, and
the crude solid was purified by chromatography (SiO2, gradient
elution with hexane/CH2Cl2/EtOAc 2:1:1 Ǟ 1:1:1 Ǟ CH2Cl2/
EtOAc 1:1) to yield bis adduct 12 (18 mg, 18 μmol, 8%) in the first
fraction [Rf(SiO2, CH2Cl2/EtOAc 1:1) = 0.53]. The second fraction
[Rf (SiO2, CH2Cl2/EtOAc 1:1) = 0.30] was mono adduct 11 (20 mg,
27 μmol, 11%; NiWa Orange III). Finally, starting material 7
(22 mg, 47 μmol, 19%) was obtained as the third fraction [Rf (SiO2,
CH2Cl2/EtOAc 1:1) = 0.11].
as
a byproduct; m.p. 128 °C. UV/Vis (CH2Cl2): λmax (ε,
mol–1 dm3 cm–1) = 446 nm (6700). H NMR (500 MHz, CDCl3): δ
= 2.14 (s, 3 H), 2.64 (dd, J = 4.8, J = 18.2 Hz, 1 H), 3.15 (dd, J =
8.7, J = 18.3 Hz, 1 H), 3.40–3.51 (m, 4 H), 3.78–3.82 (m, 2 H),
3.82–3.86 (m, 2 H), 3.90 (s, 3 H), 3.91 (s, 3 H), 5.43 (dd, J = 4.8,
J = 8.6 Hz, 1 H), 6.70 (s, 2 H), 7.39 (s, 1 H), 7.40 (s, 1 H) ppm;
the two NH protons are not detectable. 13C{1H} NMR (125 MHz,
CDCl3, 330 K): δ = 20.38 (CH3), 35.72 (CH2), 37.23 (CH2), 38.47
(CH2), 41.11 (CH2), 42.02 (CH2), 51.91 (2 CH3), 67.50 (CH),
114.46 (CH), 114.60 (CH), 117.46 (C), 117.74 (C), 134.16 (2 CH),
140.50 (C), 140.93 (C), 168.02 (C), 168.11 (C), 169.64 (C), 170.54
1
Dimethyl 2-[2-(2,5-Dioxo-2,5-dihydropyrrol-1-yl)ethylamino]-5-[2-
(3-hexadecylsulfanyl-2,5-dioxopyrrolidin-1-yl)ethylamino]terephthal-
ate (NiWa Orange III) (11): M.p. 186 °C. UV/Vis (CH2Cl2): λmax
(ε, mol–1 dm3 cm–1) = 468 nm (2500). 1H NMR (500 MHz, CDCl3):
δ = 0.88 (t, J = 6.9 Hz, 3 H), 1.22–1.30 (m, 23 H), 1.32–1.39 (m, 2
H), 1.54–1.66 (m, 3 H), 2.52 (dd, J = 3.6, J = 18.6 Hz, 1 H), 2.71
(ddd, J = 6.8, J = 8.3, J = 15.0 Hz, 1 H), 2.85 (ddd, J = 6.3, J =
8.7, J = 14.4 Hz, 1 H), 3.14 (dd, J = 8.0, J = 18.8 Hz, 1 H), 3.43
(q, J = 6.5 Hz, 4 H), 3.72 (dd, J = 3.6, J = 8.1 Hz, 1 H), 3.79–3.83
(m, 4 H), 3.90 (s, 3 H), 3.91 (s, 3 H), 6.70 (s, 2 H), 7.37 (s, 1 H),
7.42 (s, 1 H) ppm; the two NH protons are not detectable. 13C{1H}
NMR (125 MHz, CDCl3): δ = 14.05 (CH3), 22.67 (CH2), 28.83
(CH2), 29.10 (CH2), 29.20 (CH2), 29.35 (CH2), 29.50 (CH2), 29.59
(2 CH2), 29.66 (2 CH2), 29.69 (4 CH2), 31.77 (CH2), 31.93 (CH2),
36.27 (CH2), 37.11 (CH2), 38.23 (CH2), 39.33 (CH), 42.11 (CH2),
51.98 (CH3), 52.03 (CH3), 114.52 (2 CH), 117.39 (2 C), 134.18 (2
CH), 141.05 (2 C), 168.00 (2 C), 170.56 (2 C), 174.76 (C), 176.59
(2 C), 173.05 (C), 173.31 (C) ppm. IR (ATR): ν = 3355 (w), 3111
˜
(w), 2953 (w), 2848 (w), 1693 (vs), 1601 (w), 1533 (m), 1438 (m),
1405 (m), 1358 (m), 1335 (m), 1213 (vs), 1110 (s), 1040 (m), 997
(w), 964 (w), 913 (m), 873 (w), 830 (m), 788 (m), 728 (m), 696 (s),
648 (w) cm–1. HRMS (EI, 70 eV): calcd. for C24H26N4O10 [M]+
530.1649; found 530.1641.
Turn On of NiWa Orange II (8) with Glutathione (GSH), Formation
of 9: DMSO (1 mL) was added to a mixture of acetoxy adduct 8
(1.3 mg, 2.5 μmol) and GSH (10 mg, 33 μmol), and the resulting
mixture was stirred for 20 min at 23 °C. It was then diluted with
DMSO (9 mL) and further analyzed. UV/Vis (DMSO): λmax (ε,
(C) ppm. IR (ATR): ν = 3357 (w), 2919 (m), 2850 (m), 1692 (vs),
˜
1537 (m), 1439 (m), 1404 (m), 1360 (m), 1336 (m), 1220 (vs), 1112
(vs), 963 (w), 911 (w), 874 (w), 838 (m), 788 (s), 721 (w), 697 (s)
cm–1. HRMS (EI, 70 eV): calcd. for C38H56N4O8S [M]+ 728.3819;
found 728.3806.
mol–1 dm3 cm–1) = 469 nm (6700); fluorescence (DMSO): λex
=
469 nm; λem = 568 nm. HRMS (ESI, pos. mode): calcd. for
C34H44N7O16S [M + H]+ 838.2565; found 838.2551.
Dimethyl 2,5-Bis{2-[3-(hexadecylsulfanyl)-2,5-dioxopyrrolidin-1-yl]-
Dimethyl 2,5-Bis{2-[3-(benzylsulfanyl)-2,5-dioxopyrrolidin-1-yl]eth-
ylamino}terephthalate (10): A solution of bismaleinimide 7 (25 mg,
53 μmol), BnSH (32 mg, 0.26 mmol) and NEt3 (19 mg, 0.19 mmol) 467 nm; λem = 561 nm. H NMR (500 MHz, CDCl3, 328 K): δ =
ethylamino}terephthalate (12): M.p. 165 °C. UV/Vis (CH2Cl2): λmax
(ε, mol–1 dm3 cm–1) = 467 nm (4200); fluorescence (CH2Cl2): λex
=
1
in CH2Cl2 (2 mL) was stirred at 23 °C for 1 d. The solvent was
removed under reduced pressure, and the residue was chromato-
graphed [SiO2, gradient elution hexane/EtOAc 2:1 Ǟ 1:1 Ǟ EtOAc,
Rf (hexane/EtOAc 2:1) = 0.09] to yield the compound 10 (33 mg,
46 μmol, 87%) as a red solid, m.p. 70 °C. UV/Vis (CH2Cl2): λmax
0.89 (t, J = 6.8 Hz, 6 H), 1.24–1.33 (m, 48 H), 1.33–1.45 (m, 4 H),
1.56–1.69 (m, 4 H), 2.51 (dd, J = 3.6, J = 18.5 Hz, 2 H), 2.70–2.76
(m, 2 H), 2.85 (ddd, J = 6.3, J = 8.1, J = 18.7 Hz, 2 H), 3.09 (dd,
J = 9.1, J = 18.5 Hz, 2 H), 3.45 (t, J = 6.3 Hz, 4 H), 3.68 (dd, J =
3.7, J = 9.0 Hz, 2 H), 3.77–3.82 (m, 4 H), 3.91 (s, 6 H), 7.37 (s, 2
H) ppm; the two NH protons are not detectable. 13C{1H} NMR
(125 MHz, CDCl3, 328 K): δ = 14.00 (2 CH3), 22.67 (2 CH2), 28.83
(2 CH2), 29.15 (2 CH2), 29.20 (2 CH2), 29.34 (2 CH2), 29.50 (2
(ε, mol–1 dm3 cm–1) = 467 nm (3400); fluorescence (CH2Cl2): λex
=
1
467 nm; λem = 559 nm. H NMR (500 MHz, CDCl3, 330 K): δ =
2.43 (dd, J = 3.9, J = 18.6 Hz, 2 H), 2.96 (dd, J = 9.2, J = 18.6 Hz,
2 H), 3.47 (t, J = 6.1 Hz, 4 H), 3.54 (dd, J = 3.9, J = 9.2 Hz, 2 H), CH2), 29.59 (2 CH2), 29.69 (4 CH2), 29.69 (6 CH2), 31.80 (2 CH2),
3.77–3.84 (m, 4 H), 3.88 (d, J = 13.4 Hz, 2 H), 3.91 (s, 6 H), 4.19 31.93 (2 CH2), 36.29 (2 CH2), 38.39 (2 CH2), 39.39 (2 CH), 42.22
(d, J = 13.5 Hz, 2 H), 6.87 (br. s, 2 H), 7.27–7.30 (m, 2 H), 7.31– (2 CH2), 51.90 (2 CH3), 114.53 (2 CH), 117.60 (2 C), 140.75 (2 C),
7.36 (m, 4 H), 7.37–7.41 (m, 6 H) ppm. 13C{1H} NMR (125 MHz, 168.07 (2 C), 174.62 (2 C), 176.57 (2 C) ppm; signals for two CH2
CDCl3, 330 K): δ = 35.66 (2 CH2), 36.00 (2 CH2), 37.95 (2 CH), groups at approx. 37 ppm are not detectable. IR (ATR): ν = 3372
˜
38.41 (2 CH2), 41.13 (2 CH2), 51.87 (2 CH3), 114.43 (2 CH), 117.56
(w), 2917 (s), 2850 (m), 1769 (w), 1692 (vs), 1539 (m), 1467 (m),
(2 C), 127.53 (2 CH), 128.69 (4 CH), 129.16 (4 CH), 136.94 (2 C), 1439 (m), 1401 (m), 1342 (m), 1220 (s), 1203 (s), 1116 (s), 949 (w),
140.79 (2 C), 168.07 (2 C), 174.48 (2 C), 176.52 (2 C) ppm. IR
873 (w), 788 (m), 720 (w), 694 (w) cm–1. HRMS (EI, 70 eV): calcd.
for C54H90N4O8S2 [M]+ 986.6200; found 986.6209.
(ATR): ν = 3373 (m), 3060 (w), 3030 (w), 2951 (m), 2859 (w), 1177
˜
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
9